The latest statistics show that home cultivation of marijuana is burgeoning, with potentially profound consequences for the entire industry. Read More

Technology all-stars are part of the earnings season line-up this week and their operating results will loom large over the broader market. Read More

Instead of trying to get rich quickly in cryptocurrencies, go for the sure thing. Keep those speculative investments as a small portion of your portfolio. Read More

Despite the coronavirus Delta variant, the stock rally continues, with the Dow surpassing 35K for the first time. So what gives? Read More

Now that the major opioid lawsuit has been settled, we wouldn’t be surprised to see JNJ follow Merck's lead and break up into smaller pieces. Read More

Second-quarter operating results so far from the S&P 500 are crushing expectations, a stellar performance that’s helping propel stocks to new highs. Read More

The deadlier and more contagious coronavirus mutation is a threat to public health and the economy, but paradoxically, it's manna for pot sales. Read More

As stock markets around the world bounce back from the latest bout of COVID jitters, overseas equities offer future growth at a discount. Read More

This ETF is a good way to hedge a stock portfolio against another outbreak of COVID-19 that shuts down the global economy. Read More

Wall Street's mood has suddenly brightened, as investors turn their attention from COVID to economic growth. We pinpoint under-the-radar opportunities. Read More